4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with T-Cell Lymphoma in 1 studies
WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzec, M | 1 |
| Kasprzycka, M | 1 |
| Ptasznik, A | 1 |
| Wlodarski, P | 1 |
| Zhang, Q | 1 |
| Odum, N | 1 |
| Wasik, MA | 1 |
1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and T-Cell Lymphoma
| Article | Year |
|---|---|
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3.
Topics: Anaplastic Lymphoma Kinase; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose | 2005 |